receptor binding in Lewy body dementia, Alzheime's and Parkinson's disease. J Neurol Sci 106:50-55, 1991
2) Fernandes HH, Trieschmann ME, Friedman JH:Treatment of psychosis in Parkinson's disease. Drug Safety 26:643-659, 2003
3) 堀口淳,笠原恭輔,糸賀基,他:パーキンソン病の臨床医学的側面.老年精医 11:1419-1431,2000
4) Iwasaki K, Satoh-Nakagawa T, Maruyama M, et al:A randomized, observer-blind, controlled trial of the traditional chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. Clin Psychiatry 66:248-252, 2005
5) Iwasaki K, Maruyama M, Tomita N, et al:Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 66:1612-1613, 2005
6) McKeith IG, Dickson DW, Lowe J, et al:Diagnosis and management of dementia with Lewy bodies.Third report of the DLB consortium. Neurology 65:1863-1872, 2005
7) Minoshima S, Foster NL, Sima AA, et al:Alzheimer's disease versus dementia with Lewy bodies:Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50:358-365, 2001
8) 森悦朗:レビー小体型認知症の幻視.老年精医誌 5:279-285,2004
9) Olanow CW, Watts RL, Koller WC:An algorithm(decision tree)for the management of Parkinnson disease(2001):Treatment guidelines. Neurology 56(Suppl 5):S1-S88, 2001
10) Perry EK, Marshall E, Kerwin J, et al:Evidence of a monoaminergic imbalance related to hallucinations in Lewy body dementia. J Neurochem 55:1454-1456, 1990